Cargando…

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD

Bacteria are isolated in more than 50% of exacerbations of chronic bronchitis (CB) and chronic obstructive pulmonary disease (COPD). The most prevalent respiratory pathogens include Gram-positive (Streptococcus pneumoniae) and Gram-negative (Haemophilus influenzae, Moraxella catarrhalis) microorgani...

Descripción completa

Detalles Bibliográficos
Autor principal:	Miravitlles, Marc
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2007
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695197/ https://www.ncbi.nlm.nih.gov/pubmed/18229559

Ejemplares similares

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results
por: Wilson, Robert, et al.
Publicado: (2012)

Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI)
por: Chuchalin, Alexander, et al.
Publicado: (2013)

Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
por: Sethi, Sanjay, et al.
Publicado: (2010)

Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
por: Cazzola, Mario, et al.
Publicado: (2015)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

Correction: Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
por: Sethi, Sanjay, et al.
Publicado: (2010)

Association of body mass index and COPD exacerbation among patients with chronic bronchitis
por: Shin, Sun Hye, et al.
Publicado: (2022)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review
por: Miravitlles, Marc, et al.
Publicado: (2016)

Greatest International ANtiinfective Trial (GIANT) with moxifloxacin in the treatment of acute exacerbation of chronic bronchitis: subanalysis of Chinese data of a global, multicenter, noninterventional study
por: Feng, Yulin, et al.
Publicado: (2010)

Chronic bronchial infection in COPD. Is there an infective phenotype?
por: Matkovic, Zinka, et al.
Publicado: (2013)

Moxifloxacin in the Outpatient Treatment of Moderate Exacerbations of Chronic Obstructive Pulmonary Disease
por: Minov, Jordan, et al.
Publicado: (2018)

Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis
por: Jivcu, Cristian, et al.
Publicado: (2009)

Infection in acute exacerbations of chronic bronchitis: a clinical perspective
por: Read, R.C.
Publicado: (1999)

Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations
por: Ball, Peter
Publicado: (1995)

The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management
por: Martinez-Garcia, Miguel Angel, et al.
Publicado: (2022)

COPD symptoms in the morning: impact, evaluation and management
por: Roche, Nicolas, et al.
Publicado: (2013)

Stepwise management of COPD: What is next after bronchodilation?
por: Miravitlles, Marc, et al.
Publicado: (2023)

The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units
por: Sundh, Josefin, et al.
Publicado: (2015)

COPD heterogeneity: implications for management
por: Barrecheguren, Miriam, et al.
Publicado: (2016)

Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT(®) studies
por: Miravitlles, Marc, et al.
Publicado: (2009)

Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2013)

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis
por: Blasi, Francesco, et al.
Publicado: (2007)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

COPD management: role of symptom assessment in routine clinical practice
por: van der Molen, Thys, et al.
Publicado: (2013)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

A study of infective and other factors in exacerbations of chronic bronchitis
por: McHardy, Valentine U., et al.
Publicado: (1980)

Chronic Bronchitis
Publicado: (1882)

Understanding the impact of symptoms on the burden of COPD
por: Miravitlles, Marc, et al.
Publicado: (2017)

Impact of heterozygote CFTR Mutations in COPD patients with Chronic Bronchitis
por: Raju, S Vamsee, et al.
Publicado: (2014)

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD
por: Wilson, Robert, et al.
Publicado: (2015)

Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones
por: Mensa, J., et al.
Publicado: (2006)

Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia
por: Zhanel, George G, et al.
Publicado: (2006)

The Economic Impact of Acute Exacerbations of Chronic Bronchitis in the United States and Canada: A Literature Review
por: Halpern, Michael T., et al.
Publicado: (2003)

Nebulized corticosteroids in the management of acute exacerbation of COPD
por: Gaude, G. S., et al.
Publicado: (2010)

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
por: Santos, Salud, et al.
Publicado: (2016)

The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD
por: Miravitlles, Marc, et al.
Publicado: (2015)

Fluoroquinolone-Resistant Group B Streptococci in Acute Exacerbation of Chronic Bronchitis
por: Tazi, Asmaa, et al.
Publicado: (2008)

Antibacterials and Acute Exacerbation of Chronic Bronchitis: Issues for Formulary Decision Makers
por: Chock, Alan, et al.
Publicado: (2012)

Rhinovirus-Induced Exacerbations of Asthma and COPD
por: Hershenson, Marc B.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_d6rrc67qkq0uhgeaop5o8kbdd4